Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc (CRNX) is known on NASDAQ - United States, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerCRNX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodQ2 2026
- RevenueUSD 25.12M
- Net income-USD 120.86M
- Free cash flow-USD 94.71M
- Gross margin99.4%